Since the primary hypothesis underlying our study was the existence of a direct effect of VIP on human osteoclastogenesis and osteoclast function, we decided first to map the expression of VIP receptors in human osteoclast precursors isolated from both healthy donors and early arthritis patients, and in the respective mature osteoclast differentiated in vitro. The gene discussed is VIP; the disease is arthritic joint disease.